Thumbnail

Covid-19 complicated by high Venous Thromboembolism (VTE) and bleed risk in critically ill patients.

  • Study reports abnormally high VTE and high bleed risk in critically ill Covid-19 patients and calls for more effective prevention strategies.
  • Clinicians at NHS hospitals are supporting the care of Covid-19 patients with the use of geko™ devices to reduce the risk of blood clots in the most at risk patients.
 Learn more Contact us

VTE Publications

Recent Randomized Trials of Antithrombotic Therapy for Patients With COVID-19

Recent Randomized Trials of Antithrombotic Therapy for Patients With COVID-19

View
Ischemic stroke in COVID-19: positive patients an overview of SARS-CoV-2 and thrombotic mechanisms for the neurointerventionalist

Ischemic stroke in COVID-19: positive patients an overview of SARS-CoV-2 and thrombotic mechanisms for the neurointerventionalist

View
COVID-19 and coagulation bleeding and thrombotic manifestations of SARS-CoV-2 infection

COVID-19 and coagulation bleeding and thrombotic manifestations of SARS-CoV-2 infection

View
Thrombosis, Bleeding, and the Effect of Anticoagulation on Survival in Critically Ill Patients with Covid-19 in the United States

Thrombosis, Bleeding, and the Effect of Anticoagulation on Survival in Critically Ill Patients with Covid-19 in the United States

View
Risk assessment of venous thromboembolism and bleeding in Covid-19 patients

Risk assessment of venous thromboembolism and bleeding in Covid-19 patients

View
Attention should be paid to venous thromboembolism prophylaxis in the management of Covid-19

Attention should be paid to venous thromboembolism prophylaxis in the management of Covid-19

View
Back to VTE Prevention Resources

Firstkind Ltd
Hawk House,
Peregrine Business Park,
Gomm Road
High Wycombe,
HP13 7DL

© 2023 Firstkind Limited – geko™ and OnPulse™ are registered trademarks of Sky Medical Technology Ltd.